MedPath

Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control

Recruiting
Conditions
Myopia
Healthy
Orthokeratology
Registration Number
NCT06647472
Lead Sponsor
Vejle Hospital
Brief Summary

The key objective of the study is to gain an understanding of the biochemical processes that contribute to orthokeratology lenses being more effective in specific individuals compared to others. With this knowledge, we hope to optimize treatment effectiveness in those currently experiencing less favorable outcomes from treatment in the future.

The primary aim is to investigate differences in protein levels in children using orthokeratology lenses with various effects of myopia control.

Hypothesis: There is a significant difference in the expression of molecules in children with various effects of myopia control.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Children treated with orthokeratology lenses.
  • Children on or above the 95th percentile of myopia growth curves for European children at the time of treatment initiation.
  • Treatment and follow-up duration ≥ 6 months.
Read More
Exclusion Criteria
  • Current use of eye drops.
  • Objective signs of dry eyes on slit-lamp examination.
  • Active eye infection.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference in protein levels measured by mass spectrometry label-free quantification (LFQ) between children using orthokeratology lenses with different levels of myopia control effectivenessAt baseline
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Øjenafdelingen, Vejle Sygehus

🇩🇰

Vejle, Denmark

© Copyright 2025. All Rights Reserved by MedPath